After the impact: extracellular vesicles and the opportunity to limit secondary brain injury.

Authors

Daniel C Anthony

Published in

Brain, behavior, and immunity. Pages 107037. Sep 28, 2026. Epub Sep 28, 2026.

Abstract

Traumatic brain injury triggers inflammatory processes that can persist long after the mechanical insult. This commentary examines the award-winning study by Kodali and colleagues, in which a single intranasal dose of human mesenchymal stromal cell-derived extracellular vesicles 90 min after controlled cortical impact suppressed NLRP3-p38/MAPK signalling and prevented chronic cognitive and affective dysfunction in mice. The study combines a clinically attractive administration route with durable functional effects, helping to explain its rapid influence. Translation will nevertheless depend on establishing human intranasal delivery, defining active cargo and mechanisms, and developing reproducible potency and release assays for a heterogeneous biological product. The work is important because it suggests that early modulation of post-traumatic inflammation may alter the long-term course of brain injury.

PMID:
42805422
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.